Sensus Healthcare, Inc., a Delaware limited liability company, was formed on May 7, 2010. The company is a medical device company dedicated to providing highly effective, non-invasive, cost-effective treatments for both neoplastic and non-neoplastic skin conditions. Using a proprietary low-energy X-ray technology known as superficial radiation therapy (" SRT "), which is based on more than ten years of dedicated research and development, the company has successfully incorporated SRT into a portfolio of therapeutic devices: SRT-100TM, SRT-100 + TM and SRT-100 VisionTM. To date, SRT technology has been used to effectively and safely treat both neoplastic and non-neoplastic skin diseases in hundreds of thousands of patients worldwide.